Bioorganic and Medicinal Chemistry Letters p. 1077 - 1082 (1998)
Update date:2022-08-02
Topics:
Patel, Mona
Kaltenbach III, Robert F.
Nugiel, David A.
McHugh Jr., Robert J.
Jadhav, Prabhakar K.
Bacheler, Lee T.
Cordova, Beverly C.
Klabe, Ronald M.
Erickson-Viitanen, Susan
Garber, Sena
Reid, Carol
Seitz, Steven P.
Cyclic urea SD 146, a potent HIV protease inhibitor bearing a flat resistance profile, possessed poor solubility and bioavailability, which precluded further development of the compound. In an effort to improve upon the pharmacokinetic profile of the compound, several analogs modified at the P1/P1' residues were prepared and evaluated. Several of those compounds displayed significant improvement of physical properties.
View MoreSichuan Sangao Biochemical Co., Ltd
Contact:+86-28-84874233
Address:19F, Bldg.2, Shudu Center, Tianfu 2nd St., Hi-tech zone, Chengdu 610041, Sichuan Province, China.
Forsman Scientific(Beijing)co.,Ltd.
Contact:+86-10-64646565
Address:Rm No.1301, Building-2, No. A-13 Beiyuan Road, Chaoyang District Beijing, China, PR,
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
Hubei Honch Pharmaceutical Co.,Ltd
Contact:86-713-7222018
Address:Li Shizhen Pharmaceutical Industry park, Qichun County, Hubei Province,China
shanghai hekang chemical co.ltd
Contact:021-54173790
Address:328 WuHe Road, Building #A, 2nd Floor, Minhang, Shanghai 201109, China
Doi:10.1039/C1968001400b
(1968)Doi:10.1021/ic50022a024
(1964)Doi:10.1021/om980222u
(1998)Doi:10.1021/jp981158x
(1998)Doi:10.1021/jo0478609
(2005)Doi:10.1021/ja01464a040
(1961)
